817 related articles for article (PubMed ID: 9766506)
41. Promegapoietin, a family of chimeric growth factors, supports megakaryocyte development through activation of IL-3 and c-Mpl ligand signaling pathways.
Doshi PD; Giri JG; Abegg AL; Favara JP; Huynh MS; Kahn LE; Minnerly JC; Pegg LE; Villani-Price D; Siegel NR; Staten NR; Thomas JW; McKearn JP; Smith WG
Exp Hematol; 2001 Oct; 29(10):1177-84. PubMed ID: 11602319
[TBL] [Abstract][Full Text] [Related]
42. K-252a-induced polyploidization and differentiation of a human megakaryocytic cell line, Meg-J: transient elevation and subsequent suppression of cyclin B1 and cdc2 expression in the process of polyploidization.
Iwabe K; Teramura M; Yoshinaga K; Kobayashi S; Hoshikawa Y; Maeda T; Hatakeyama M; Mizoguchi H
Br J Haematol; 1998 Aug; 102(3):812-9. PubMed ID: 9722312
[TBL] [Abstract][Full Text] [Related]
43. Regulation of megakaryocytopoiesis by thrombopoietin and stromal cells.
Nagata Y; Nagahisa H; Nagasawa T; Todokoro K
Leukemia; 1997 Apr; 11 Suppl 3():435-8. PubMed ID: 9209416
[TBL] [Abstract][Full Text] [Related]
44. Stem cell factor synergistically enhances thrombopoietin-induced STAT5 signaling in megakaryocyte progenitors through JAK2 and Src kinase.
Drayer AL; Boer AK; Los EL; Esselink MT; Vellenga E
Stem Cells; 2005 Feb; 23(2):240-51. PubMed ID: 15671147
[TBL] [Abstract][Full Text] [Related]
45. PI3K/Akt/FOXO3a pathway contributes to thrombopoietin-induced proliferation of primary megakaryocytes in vitro and in vivo via modulation of p27(Kip1).
Nakao T; Geddis AE; Fox NE; Kaushansky K
Cell Cycle; 2008 Jan; 7(2):257-66. PubMed ID: 18256550
[TBL] [Abstract][Full Text] [Related]
46. Differential constitutive activation between STAT-related proteins and MAP kinase in primary acute myelogenous leukaemia.
Hayakawa F; Towatari M; Iida H; Wakao H; Kiyoi H; Naoe T; Saito H
Br J Haematol; 1998 Jun; 101(3):521-8. PubMed ID: 9633897
[TBL] [Abstract][Full Text] [Related]
47. Interleukin-6 dependent induction of the cyclin dependent kinase inhibitor p21WAF1/CIP1 is lost during progression of human malignant melanoma.
Flørenes VA; Lu C; Bhattacharya N; Rak J; Sheehan C; Slingerland JM; Kerbel RS
Oncogene; 1999 Jan; 18(4):1023-32. PubMed ID: 10023678
[TBL] [Abstract][Full Text] [Related]
48. Differentiation induced by the c-Mpl cytokine receptor is blocked by mutant Shc adaptor protein.
Hill RJ; Zozulya S; Lu YL; Hollenbach PW; Joyce-Shaikh B; Bogenberger J; Gishizky ML
Cell Growth Differ; 1996 Sep; 7(9):1125-34. PubMed ID: 8877093
[TBL] [Abstract][Full Text] [Related]
49. Thrombopoietin supports in vitro erythroid differentiation via its specific receptor c-Mpl in a human leukemia cell line.
Yamada M; Komatsu N; Kirito K; Kashii Y; Tomizuka H; Okada K; Endo T; Fukumaki Y; Shinjo K; Abe K; Miura Y
Cell Growth Differ; 1998 Jun; 9(6):487-96. PubMed ID: 9663467
[TBL] [Abstract][Full Text] [Related]
50. A novel MPL point mutation resulting in thrombopoietin-independent activation.
Abe M; Suzuki K; Inagaki O; Sassa S; Shikama H
Leukemia; 2002 Aug; 16(8):1500-6. PubMed ID: 12145691
[TBL] [Abstract][Full Text] [Related]
51. Tyrosyl phosphorylation and DNA binding activity of signal transducers and activators of transcription (STAT) proteins in hematopoietic cell lines transformed by Bcr/Abl.
Carlesso N; Frank DA; Griffin JD
J Exp Med; 1996 Mar; 183(3):811-20. PubMed ID: 8642285
[TBL] [Abstract][Full Text] [Related]
52. Thrombopoietin-induced activation of the mitogen-activated protein kinase (MAPK) pathway in normal megakaryocytes: role in endomitosis.
Rojnuckarin P; Drachman JG; Kaushansky K
Blood; 1999 Aug; 94(4):1273-82. PubMed ID: 10438715
[TBL] [Abstract][Full Text] [Related]
53. TPO/c-mpl ligand induces tyrosine phosphorylation of multiple cellular proteins including proto-oncogene products, Vav and c-Cbl, and Ras signaling molecules.
Sasaki K; Odai H; Hanazono Y; Ueno H; Ogawa S; Langdon WY; Tanaka T; Miyagawa K; Mitani K; Yazaki Y
Biochem Biophys Res Commun; 1995 Nov; 216(1):338-47. PubMed ID: 7488109
[TBL] [Abstract][Full Text] [Related]
54. TGF beta-induced SMAD2 phosphorylation predicts inhibition of thymidine incorporation in CD34+ cells from healthy donors, but not from patients with AML after MDS.
Koschmieder S; Hofmann WK; Kunert J; Wagner S; Ballas K; Seipelt G; Hoelzer D; Ottmann OG; Kalina U
Leukemia; 2001 Jun; 15(6):942-9. PubMed ID: 11417481
[TBL] [Abstract][Full Text] [Related]
55. Induction of megakaryocytopoiesis and thrombocytopoiesis by JTZ-132, a novel small molecule with thrombopoietin mimetic activities.
Inagaki K; Oda T; Naka Y; Shinkai H; Komatsu N; Iwamura H
Blood; 2004 Jul; 104(1):58-64. PubMed ID: 15001470
[TBL] [Abstract][Full Text] [Related]
56. Interleukin-3-induced activation of the JAK/STAT pathway is prolonged by proteasome inhibitors.
Callus BA; Mathey-Prevot B
Blood; 1998 May; 91(9):3182-92. PubMed ID: 9558373
[TBL] [Abstract][Full Text] [Related]
57. Distinct effects of thrombopoietin depending on a threshold level of activated Mpl in BaF-3 cells.
Millot GA; Vainchenker W; Duménil D; Svinarchuk F
J Cell Sci; 2002 Jun; 115(Pt 11):2329-37. PubMed ID: 12006617
[TBL] [Abstract][Full Text] [Related]
58. Interleukin-6-resistant melanoma cells exhibit reduced activation of STAT3 and lack of inhibition of cyclin E-associated kinase activity.
Böhm M; Schulte U; Funk JO; Raghunath M; Behrmann I; Kortylewski M; Heinrich PC; Kues T; Luger TA; Schwarz T
J Invest Dermatol; 2001 Jul; 117(1):132-40. PubMed ID: 11442760
[TBL] [Abstract][Full Text] [Related]
59. Inhibition of vascular smooth muscle cell proliferation by sodium salicylate mediated by upregulation of p21(Waf1) and p27(Kip1).
Marra DE; Simoncini T; Liao JK
Circulation; 2000 Oct; 102(17):2124-30. PubMed ID: 11044431
[TBL] [Abstract][Full Text] [Related]
60. Effect of recombinant interleukin-6 and thrombopoietin on isolated guinea pig bone marrow megakaryocyte protein phosphorylation and proplatelet formation.
Leven RM; Clark B; Tablin F
Blood Cells Mol Dis; 1997 Aug; 23(2):252-68. PubMed ID: 9410469
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
